These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32144792)

  • 1. GYY4137 exhibits anti-atherosclerosis effect in apolipoprotein E (-/-) mice via PI3K/Akt and TLR4 signalling.
    Zheng Y; Lv P; Huang J; Ke J; Yan J
    Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1231-1239. PubMed ID: 32144792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.
    Liu Z; Han Y; Li L; Lu H; Meng G; Li X; Shirhan M; Peh MT; Xie L; Zhou S; Wang X; Chen Q; Dai W; Tan CH; Pan S; Moore PK; Ji Y
    Br J Pharmacol; 2013 Aug; 169(8):1795-809. PubMed ID: 23713790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
    Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
    Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCK inhibitor attenuates atherosclerosis in ApoE
    Liu J; Guo Z; Zhang Y; Wu T; Ma Y; Lai W; Guo Z
    J Mol Cell Cardiol; 2020 Feb; 139():87-97. PubMed ID: 31972265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway.
    Li J; Ma J; Li M; Tao J; Chen J; Yao C; Yao S
    Life Sci; 2021 Apr; 271():119192. PubMed ID: 33577850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atmospheric fine particulate matter exposure exacerbates atherosclerosis in apolipoprotein E knockout mice by inhibiting autophagy in macrophages via the PI3K/Akt/mTOR signaling pathway.
    Wan Q; Yang M; Liu Z; Wu J
    Ecotoxicol Environ Saf; 2021 Jan; 208():111440. PubMed ID: 33039868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis.
    Pi S; Mao L; Chen J; Shi H; Liu Y; Guo X; Li Y; Zhou L; He H; Yu C; Liu J; Dang Y; Xia Y; He Q; Jin H; Li Y; Hu Y; Miao Y; Yue Z; Hu B
    Autophagy; 2021 Apr; 17(4):980-1000. PubMed ID: 32160082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of total flavonoids of Ziziphora clinopodioides in improving atherosclerosis by regulating PI3K/Akt/mTOR pathway].
    Ma XY; Zhao HR; Qiao HL; Zeng YC; Zhang XM
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):465-471. PubMed ID: 36725236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
    Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
    J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. San Jie Tong Mai Fang Protects Against Atherosclerosis Progression by Regulating Macroautophagy through the PI3K/AKT/mTOR Signaling Pathway.
    Li P; Li H; Li X; Li S; Xu H; Cui J; Cheng G; Liu Y; Xu X; Xin Y; Liu A
    J Cardiovasc Pharmacol; 2023 Oct; 82(4):333-343. PubMed ID: 37506377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV Mediates the PI3K/Akt/mTOR Pathway to Alleviate Injury and Modulate the Composition of Intestinal Flora in ApoE
    Sun D; Wang Y; Pang B; Jiang L
    Discov Med; 2024 May; 36(184):1070-1079. PubMed ID: 38798265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT/SERBP-1 pathway regulates
    Liu R; Sun Y; Di D; Zhang X; Zhu B; Wu H
    Pharm Biol; 2023 Dec; 61(1):473-487. PubMed ID: 36825364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE
    Gu L; Ye P; Li H; Wang Y; Xu Y; Tian Q; Lei G; Zhao C; Gao Z; Zhao W; Tan S
    FASEB J; 2019 Apr; 33(4):4836-4850. PubMed ID: 30601695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.
    Feng X; Du M; Li S; Zhang Y; Ding J; Wang J; Wang Y; Liu P
    Phytomedicine; 2023 Apr; 112():154684. PubMed ID: 36738477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.
    Wang XQ; Wan HQ; Wei XJ; Zhang Y; Qu P
    Mol Med Rep; 2016 Jul; 14(1):49-56. PubMed ID: 27176130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
    Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
    J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydatin alleviates high-fat diet induced atherosclerosis in apolipoprotein E-deficient mice by autophagic restoration.
    Xiong Q; Yan Z; Liang J; Yuan J; Chen X; Zhou L; Hu Y; Wu J; Jing Y; Zhang Q; Li H; Shi Y
    Phytomedicine; 2021 Jan; 81():153301. PubMed ID: 33243482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-217 inhibits apoptosis of atherosclerotic endothelial cells via the TLR4/PI3K/Akt/NF-κB pathway.
    Zhang B; Zhang YF; Li R; Zhao L; Qin SG; Pan LF; Gao YX
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12867-12877. PubMed ID: 33378037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities.
    Zhang X; Qin Y; Wan X; Liu H; Lv C; Ruan W; He L; Lu L; Guo X
    J Transl Med; 2021 Feb; 19(1):62. PubMed ID: 33568202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.